Assenagon Asset Management
MGNX icon

Assenagon Asset Management’s MacroGenics MGNX Stock Holding History

Assenagon Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-748,679
Closed -$4.01M – 1431
2023
Q2 		$4.01M Sell
748,679
-743,833
-50% -$4.59M 0.01% 558
2023
Q1 		$10.7M Hold
1,492,512
– – 0.04% 371
2022
Q4 		$10M Sell
1,492,512
-305,746
-17% -$1.68M 0.04% 378
2022
Q3 		$6.22M Sell
1,798,258
-2,405
-0.1% -$9.2K 0.02% 437
2022
Q2 		$5.31M Buy
1,800,663
+547,004
+44% +$2.88M 0.02% 526
2022
Q1 		$11M Buy
1,253,659
+1,079,273
+619% +$11.9M 0.03% 348
2021
Q4 		$2.8M Buy
174,386
+150,850
+641% +$2.84M 0.01% 702
2021
Q3 		$493K Sell
23,536
-2,404
-9% -$57.9K ﹤0.01% 1069
2021
Q2 		$697K Buy
25,940
+4,019
+18% +$118K ﹤0.01% 977
2021
Q1 		$698K Buy
+21,921
New +$532K ﹤0.01% 982
2020
Q3 		– Sell
-176,072
Closed -$4.92M – 1264
2020
Q2 		$4.92M Buy
+176,072
New +$3.06M 0.03% 332

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management's MGNX Position: Q3 2023 in Review

Assenagon Asset Management sold out of MacroGenics (MGNX) in Q3 2023, closing a stake of 748,679 shares — an estimated $4.01M sold.

Assenagon Asset Management first reported a position in MGNX in Q2 2020 and held it in 11 quarters. The position peaked at $11M in Q1 2022. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2023.

  • Assenagon Asset Management reported no remaining MacroGenics position as of Q3 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 748,679 MacroGenics shares in Q3 2023, an estimated $4.01M.
  • Assenagon Asset Management first reported a position in MacroGenics in Q2 2020 and held it in 11 quarters.
  • Assenagon Asset Management's MacroGenics position peaked at $11M in Q1 2022.
  • 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2023.

Based on Assenagon Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.